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CC BY-NC-ND license (http://creativeBackground: Infection is the most common predisposing factor for diabetic ketoacidosis (DKA);
however, studies are rare that have investigated the clinical outcomes of septic patients with
infection-precipitated DKA.
Methods: A retrospective cohort study was conducted at a tertiary hospital from 2004 to 2013.
Patients with DKA in whom the presence of a predisposing infection was confirmed were
enrolled. Characteristics at initial presentation, primary infection sources, and causative mi-
croorganisms were compared between the nonacute kidney injury (non-AKI) group and acute
kidney injury (AKI) group at each stage. Risk factors for the development of failure-stage
AKI and its outcomes were also analyzed.
Results: One hundred and sixty DKA episodes were assessed. The most common infection sites
were the urinary and respiratory tracts. The leading causative microorganism was Escherichia
coli, followed by Klebsiella pneumoniae. A complicated/severe infection state [odds ratio
(OR), 15.27; p < 0.001] and a high level of C-reactive protein (OR, 1.012; p < 0.001) were inde-
pendently associated with bacteremia. Corrected sodium (Na; OR, 1.062; p Z 0.039), initialInfectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaoh-
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664 Y.-C. Cheng et al.plasma glucose (OR, 1.003; p Z 0.041), severe grade of DKA (OR, 13.41; p Z 0.045), and the
Acute Physiology and Chronic Health Evaluation (APACHE) II score (OR, 1.08; p Z 0.033) were
identified as independent risk factors for the development of failure-stage AKI among septic
patients with infection-precipitated DKA. Patients with failure-stage AKI had a higher fre-
quency of incomplete recovery of renal function (20.4% of patients in failure vs. 5.9% of pa-
tients in risk and injury, p Z 0.009). Bacteremia independently predicted the absence of
complete recovery of renal function (OR, 5.86; p Z 0.038).
Conclusion: For patients with infection-precipitated DKA, the clinician should aggressively
monitor renal function if a patient presents with risk factors associated with failure-stage
AKI. Furthermore, bacteremia predicts a poor renal prognosis.
Copyright ª 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Infection is the most common predisposing factor for the
development of hyperglycemic crises, diabetic ketoacidosis
(DKA) and hyperosmolar hyperglycemic state; it has an
estimated range of 32e60%.1 Among the predisposing factors
for hyperglycemic crises, infection is the most common
cause of death. However, previous studies are lacking that
address in detail the infection source and microbiological
characteristics of septic patientswith infection-precipitated
DKA. Potential complications of diabetic ketoacidosis (DKA)
include electrolyte imbalance, dehydration, cerebral and
peripheral venous thrombosis, rhabdomyolysis, and acute
renal failure.2 Diabetic ketoacidosis can result in severe fluid
depletion that is accompanied by marked metabolic distur-
bance, although a low incidence of acute renal failure in
patients with DKA was reported in a previous study.3 How-
ever, acute kidney injury (AKI) is an independent risk factor
formortality in critically ill patients.4e7 Furthermore, amore
severe stage of AKIdas classified by Risk, Injury, Failure,
Loss, End-stage Kidney Disease (RIFLE) criteria or by the
Acute Kidney Injury Network (AKIN) criteriadis associated
with increased hospital mortality.4,6,8
To further our understanding of the relationship be-
tween the infection site or the causative microorganism in
septic patients with DKA and renal involvement, especially
with regard to the severity stage of AKI in which renal
replacement therapy may be necessary or a higher mor-
tality is expected, we conducted a retrospective cohort
study to investigate the risk factors and clinical outcomes
of patients with infection-precipitated DKA that develops
into failure-stage AKI.
Materials and methods
Study design and setting
This retrospective cohort study was conducted at a tertiary
hospital in southern TaiwandKaohsiung Medical University
Hospital (Kaohsiung, Taiwan)din which medical records
were reviewed of patients who developed DKA from
January 2004 to December 2013. The protocol for this study
was reviewed and approved by the Institutional ReviewBoard of Kaohsiung Medical University Hospital (approval
number KMUH-IRB-980057). Diabetic ketoacidosis was
diagnosed in accordance with the diagnostic criteria of the
American Diabetes Association: hyperglycemia (i.e., plasma
glucose > 250 mg/dL) and high anion gap metabolic acidosis
(i.e., arterial pH < 7.30, serum bicarbonate < 18 mEq/L,
and an anion gap > 10) with positive serum or urine ke-
tones.1 In the event that a patient developed multiple DKA
episodes during the study period, each episode was evalu-
ated. Patients under the age of 18 years were excluded.
Precipitating factors of DKA were extracted. Two infectious
disease specialists confirmed the infection state and the
primary infection source with the recovered causative
microorganism, based on specific symptoms and signs, im-
aging study results, and microbiologic results from the
appropriate specimen. In the event of a disagreement, a
third specialist participated in the adjudication. To further
identify a complicated or severe infection state, we defined
complicated urinary tract infection in accordance with the
guidelines of the Association of Medical Microbiology and
Infectious Diseases Canada.9 We also defined pneumonia
with parapneumonic effusion or empyema, severe skin and
soft tissue infection with systemic inflammatory response
syndrome or deeper infection, and complicated intra-
abdominal infection, based on the clinical practice guide-
lines of the Infectious Diseases Society of America.10e13
Patients who were confirmed as having infection-
precipitated DKA were enrolled and then evaluated for
whether AKI developed in the first 48 hours after admission.
Patients in the AKI group were further divided into three
stages (i.e., “risk”, “injury”, and “failure”) on the basis of
the RIFLE classification. Demographic characteristics and
physiologic and laboratory data at the initial presentation
were compared between the non-AKI and AKI groups at
each stage. For investigation of the risk factors associated
with the development of severe AKI, for which renal
replacement therapy may be necessary or which may have
a higher than expected mortality, we compared AKI in the
failure stage and other infection-precipitated DKA episodes
(non-AKI group and AKI in the risk and injury stages). Also
investigated were the clinical outcomes of patients in
failure-stage AKI, which included the length of hospital
stay, recovery of renal function at discharge, and hospital
mortality.
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outcome
The RIFLE criteria were designed by the Acute Dialysis
Quality Initiative (ADQI) Working Group to obtain a general
definition of AKI.14 The definition and classification of AKI
were determined by the worst serum creatinine (SCr) level
in the first 48 hours after admission. Patients were deter-
mined to have developed AKI when they had a decrease in
the glomerular filtration rate (GFR) of  25% or an increase
in the SCr level of  50% (1.5 times) from the baseline. The
baseline renal function was based on the lowest known SCr
level during the preceding 3 months.
Patients who had AKI were divided into three stages
(“risk”, “injury”, and “failure”), based on the RIFLE clas-
sification. A patient who had a decrease in the GFR of  25%
or an increase in the SCr level of  50% (1.5 times) from the
baseline level was classified as being in the risk stage. A
patient who had a decrease in the GFR of  50% or an in-
crease in the SCr level of  100% (2 times) from baseline
level was classified as being in the injury stage. A patient in
the failure stage had a decrease in the GFR of  75%, an
increase in the SCr level of  200% (3 times) from the
baseline, or an absolute SCr level of  4.0 mg/dL or with an
acute increase of  0.5 mg/dL.
For patients who developed AKI, the renal outcome at
hospital discharge was defined as follows (as previously
applied): “complete recovery” if the discharge SCr level
was within 120% of the baseline level, “partial recovery” if
the discharge SCr level was 121e150% of the baseline level,
or “nonrecovery” if the discharge SCr level was > 150% of
the baseline level or if the patient was still receiving renal
replacement therapy.15
Data extraction
Demographic information and baseline laboratory data
were extracted and included age, sex, body mass index
(BMI), type of diabetes, hypertension, glycated hemoglo-
bin (HbA1c) level, baseline SCr level, and uric acid level.
Physiologic and laboratory data at the initial presentation
were recorded and included body temperature, pulse
rate, respiratory rate, mean arterial pressure, white blood
cell count, the levels of C-reactive protein, lactate, blood
urea nitrogen (BUN), SCr, serum sodium, potassium,
chloride, bicarbonate, pH value, and initial plasma
glucose level. Detected serum sodium and initial plasma
glucose were used to calculate the corrected sodium
level:
corrected sodium Z detected sodium þ (plasma
glucose  100)  0.024
and to calculate the effective blood osmolarity:
calculated blood osmolarity Z (detected
sodium  2) þ (plasma glucose O 18).
The anion gap was calculated by the following formula:
anion gap Z detected serum sodium  (serum
chloride þ serum bicarbonate).Severity of illness was further evaluated by the Acute
Physiology and Chronic Health Evaluation (APACHE) II score,
DKA severity, shock with vasopressor use, complicated or
severe infection state, and bacteremia. The DKA severity
(i.e., mild, moderate, severe) was stratified by the pH
value and the serum bicarbonate level in accordance with
the American Diabetes Association.1 A mild grade of DKA is
defined as an arterial pH value of 7.25e7.30 or serum bi-
carbonate (HCO3
e) level of 15e18 mEq/L; the moderate
grade is defined as a pH of value 7.00e7.24 or HCO3 level of
10e14 mEq/L; and the severe grade is defined as a
pH < 7.00 or HCO3 < 10 mEq/L. Data on the initial anti-
microbial therapy were also extracted. Therapy was
considered inappropriate if a patient did not receive within
24 hours from the diagnosis of sepsis at least one antimi-
crobial agent that was active in vitro to the causative
microorganism, based on the Clinical and Laboratory Stan-
dards Institute (CLSI) guidelines.16 Primary infection sour-
ces and recovered causative microorganisms, as confirmed
by the infectious disease specialists, were also recorded.
Statistical analysis
Categorical variables, expressed by proportions, were
compared using Pearson’s Chi-square test or Fisher’s exact
test. Continuous variables were expressed as the
mean  the standard deviation. The means were compared
between the two groups using the Student t test. An analysis
of variance was used for the means of more than three
groups. Multivariable logistic regression analysis was used to
assess the associated risk factors of developing failure-stage
AKI and assess the independent predictors for the poor
clinical outcome of AKI. Variables were included in the
regression analysis if they demonstrated a statistically sig-
nificant association with the outcomes of interest in the
univariable analyses or if previous studies suggested that the
variables were potential confounders or effect modifiers.
Data analyses were performed using SPSS software version
19.0 (SPSS Inc., Chicago, IL, USA). All tests were two-tailed.
A p value < 0.05 was considered statistically significant.
Results
We evaluated 403 DKA episodes that presented to our
hospital during the study period. Fifty-two episodes
occurred in patients under the age of 18 years; these pa-
tients were excluded. One hundred and sixty (39.7%) DKA
episodes, which involved 144 patients, were precipitated
by infectious diseases and were entered in the study. The
leading cause of noninfection-precipitated DKA was
noncompliance with treatment. Newly diagnosed diabetes
was also a common associated factor. Acute kidney injury
developed in 139 (86.9%) episodes of infection-precipitated
DKA, which included 27 (19.4%) episodes in the risk stage,
58 (41.7%) episodes in the injury stage, and 54 (38.8%) ep-
isodes in the failure stage (Fig. 1).
Baseline demographic characteristics and physiologic
and laboratory data at initial presentation are shown in
Table 1. Patients who had infection-precipitated DKA had a
mean age of 45.1 years, and only 11.9% patients were
elderly (i.e., older than 65 years). Furthermore, 73.8% of
Figure 1. Study design. AKI Z acute kidney injury;
DKA Z diabetic ketoacidosis.
Table 1 Demographic and clinical characteristics for infection-
Infection-precipitated DKA Total episodes Non-AKI
(n Z 160) (n Z 21)
Demographic characteristics
Age (y) 45.1  16.1 47.2  16.4
Elderly ＞65 y 19 (11.9) 4 (19.0)
Sex, male 73 (45.6) 11 (52.4)
BMI 22.2  4.6 23.6  3.7
Type 2 diabetes 118 (73.8) 17 (81.0)
Hypertension 20 (12.5) 4 (19.0)
Baseline laboratory data
HbA1C (%) 12.4  2.8 11.3  3.4
Baseline serum Cr (mg/dL) 0.88  1.03 1.77  1.95
Uric acid (mg/dL) 6.4  3.1 8.6  5.0
Presenting physiologic and laboratory data
Body temperature >38.3C
or <36.0C
45 (28.1) 6 (28.6)
Pulse rate >90/min 133 (83.1) 18 (85.7)
Respiratory rate >20/min 82 (51.2) 14 (66.7)
Mean arterial pressure (mmHg) 95.5  20.4 106.3  17.2
WBC count ( 10^3/mL) 16.7  6.7 14.3  6.6
C-reactive protein (mg/L) 103.2  128.0 76.7  109.4
BUN (mg/dL) 33.0  32.0 27.1  26.0
Serum Cr (mg/dL) 1.96  1.62 1.86  1.82
Corrected Na (mmol/L) 142.9  8.8 138.9  7.6
K (mmol/L) 4.8  1.0 4.7  0.8
Cl (mmol/L) 100.0  8.5 98.3  8.8
Initial plasma glucose (mg/dL) 569.5  227.1 435.2  145.6
Serum pH 7.127  0.140 7.136  0.122
Serum bicarbonate (mEq/L) 8.6  4.4 9.4  5.0
Anion gap 23.2  6.7 23.7  7.9
Blood osmolarity (mOsm/kg) 300.8  23.8 286.4  15.7
Lactate (mmol/L) 3.8  4.9 7.8  9.5
*p < 0.05 among the four subgroups: non-AKI, AKI in risk stage, injur
AKI Z acute kidney injury; BMI Z body-mass index; BUN Z blood
ketoacidosis; HbA1c Z glycated hemoglobin; K Z potassium; Na Z s
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mean HbA1c level of 12.4%  2.8% was evidence of poor
recent glucose control. In the analysis of variance in each
stage between the non-AKI (NA) group and AKI group at the
initial presentation, patients with failure-stage AKI (F) had
a significantly lower BMI [F < NA, p Z 0.042; F < risk (R),
p Z 0.009; F < injury (I), p Z 0.387], higher corrected
sodium (F > NA, p < 0.001; F > R, p Z 0.002; F > I,
p < 0.001), higher serum potassium (F > R, p Z 0.005;
F > I, p Z 0.007), higher initial plasma glucose (F > NA,
p < 0.001; F > R, p < 0.001; F > I, p < 0.001), and higher
calculated blood osmolarity (F > NA, p < 0.001; F > R,
p Z 0.002; F > I, p < 0.001). In addition, the APACHE II
score had a positive relevance with severity of AKI at each
stage (F > I, pZ 0.002; F > R, p < 0.001; I > R, pZ 0.01).
Table 2 and Table 3 show the primary infection sources
and recovered causative microorganisms, respectively. The
most common primary infection site for infection-
precipitated DKA was a urinary tract infection (n Z 42,
26.2%), followed by a respiratory tract infection (n Z 41,
25.7%) and skin and soft tissue infection (nZ 22, 13.8%); an
uncertain infection source represented 4.4%. The overallprecipitated diabetic ketoacidosis
AKI (n Z 139) p
Risk (n Z 27) Injury (n Z 58) Failure (n Z 54)
38.3  13.3 45.2  15.7 47.5  17.3 0.092
1 (3.7) 4 (6.9) 10 (18.5) 0.093
13 (48.1) 30 (51.7) 33 (61.1) 0.658
24.0  5.4 21.8  4.8 21.1  3.8 0.03*
19 (70.4) 42 (72.4) 40 (74.1) 0.855
2 (7.4) 7 (12.1) 7 (13.0) 0.686
13.0  2.6 12.5  2.4 12.3  3.0 0.208
0.77  0.24 0.67  0.25 0.81  1.14 < 0.001*
6.4  2.0 5.4  2.8 6.8  2.8 0.063
7 (25.9) 14 (24.1) 18 (34.0) 0.704
22 (81.5) 46 (79.3) 47 (88.7) 0.586
12 (44.4) 27 (46.6) 29 (54.7) 0.353
95.6  18.7 94.0  22.8 96.5  20.6 0.947
16.4  6.7 17.2  7.0 17.1  6.5 0.344
74.0  110.0 125.5  143.7 103.6  123.3 0.261
19.3  18.2 25.7  15.2 49.9  43.9 < 0.001*
1.36  0.40 1.61  0.60 2.66  2.32 0.001*
140.9  6.5 141.1  6.1 147.2  11.0 < 0.001*
4.5  0.8 4.7  0.9 5.2  1.2 0.012*
100.5  7.5 100.2  7.9 100.0  9.6 0.834
509.7  171.8 509.7  167.7 712.9  259.9 < 0.001*
7.143  0.129 7.143  0.152 7.100  0.137 0.375
9.9  5.0 8.6  4.6 7.5  3.4 0.094
20.8  6.0 22.7  6.6 25.0  6.5 0.076
296.9  17.5 295.9  18.2 313.4  28.5 < 0.001*
2.0  1.3 2.2  1.4 4.2  4.5 0.002*
y stage, failure stage.
urea nitrogen; Cl Z chlorine; Cr Z creatinine; DKA Z diabetic
odium; WBC Z white blood cell.
Table 2 Primary infection sources in infection-
precipitated diabetic ketoacidosis
Primary infection sources Total episodes
n Z 160
Urinary tract infection 33 (20.6)
Complicated urinary tract infection 9 (5.6)
Respiratory tract infection 35 (21.9)
Pneumonia with parapneumonic effusion 6 (3.8)
Skin and soft tissue infection 12 (7.5)
Severe SSTI with SIRS 10 (6.3)
Intra-abdominal infection 13 (8.1)
Complicated intra-abdominal infection 8 (5.0)
Bone and joint infection 2 (1.3)
Severe BJI with SIRS 1 (0.6)
Catheter-related bloodstream infection 2 (1.3)
CNS infection 1 (0.6)
Multifocal 11 (6.9)
Uncertained 7 (4.4)
All data are presented as n (%).
BJIZ bone and joint infection; CNSZ central nervous system;
DKA Z diabetic ketoacidosis; SIRS Z systemic inflammatory
response syndrome; SSTI Z skin and soft tissue infection.
Infection-precipitated DKA and AKI 667complicated or severe infection states accounted for 21.3%
of cases. Ninety-three causative microorganisms were ob-
tained from 29 blood specimens, 26 urine specimens, 18 pus
specimens, 13 sputum specimens, and four other speci-
mens. The leading causative microorganism was Escherichia
coli (n Z 26, 30.0%), followed by Klebsiella pneumoniae
(nZ 25, 26.9%) and Staphylococcus aureus (nZ 14, 15.1%).
No significant relationship between either primary infection
sources or causative microorganisms and the developmentTable 3 Causative microorganism in infection-
precipitated diabetic ketoacidosis
Causative microorganisms Total (n Z 93)
Bacteria Fungus
Gram-negative cocci 64 (68.8) Candida
albicans
2 (2.2)
Escherichia coli 26 (30.0)
Klebsiella pneumoniae 25 (26.9)
Pseudomonas aeruginosa 5 (5.4)
Proteus mirabilis 4 (4.3)
Serratia marcescens 1 (1.1)
Enterobacter spp. 1 (1.1)
Acinetobacter spp. 1 (1.1)
Burkholderia pseudomallei 1 (1.1)
Gram-positive cocci 24 (25.8)
Staphylococcus aureus 14 (15.1)
Group B Streptococcus 5 (5.4)
Coagulase-negative
Staphylococcus
3 (3.2)
Enterococcus spp. 2 (2.2)
Others
Mycobacterium tuberculosis
complex
3 (3.2)
All data are presented as n (%).of failure-stage AKI or mortality was noted in this study.
However, a complicated or severe infection state (adjusted
OR, 15.27; p < 0.001) and a higher C-reactive protein level
(adjusted OR, 1.012; p < 0.001) were independently asso-
ciated with bacteremia.
At initial presentation, patients with infection-
precipitated DKA who developed failure-stage
AKIdcompared to the non-AKI group and patients with
AKI at the risk and injury stagesdhad a significantly higher
corrected sodium (Na) level (147.2  11 mmol/L vs.
140.6  6.5 mmol/L; p < 0.001), higher initial plasma
glucose level (712.9  259.9 mg/dL vs. 495.1  165.8 mg/
dL, p < 0.001), greater severity of DKA (p Z 0.003), and
higher APACHE II score (21.3  7.2 vs. 16.7  5.3, p < 0.001)
(Table 4). In multivariable analysis, corrected Na level
(adjusted OR, 1.062; p Z 0.039), initial plasma glucose
level (adjusted OR, 1.003; pZ 0.041), severe grade of DKA
(adjusted OR, 13.41; p Z 0.045), and APACHE II score
(adjusted OR, 1.08; p Z 0.033) were independent risk
factors for developing failure-stage AKI among the septic
patients with DKA.
Clinical outcomes
Nine patients died in hospital, thereby contributing to a
hospital mortality rate of 5.6% in septic patients with DKA
(Table 5). No significant difference was evident in hospital
mortality between the non-AKI group and AKI group at each
stage. In addition, no significant difference was observed in
the length of hospital stay and hospital mortality in septic
patients with infection-precipitated DKA who developed
failure-stage AKI (Table 6). For renal outcome at discharge,
123 (88.5%) of 139 AKI episodes showed complete recovery
of renal function, 6 (4.3%) episodes showed partial renal
recovery, whereas 10 (8.1%) episodes did not show recovery
of renal function (Table 5). Patients who developed failure-
stage AKI had incomplete recovery of renal function at
discharge more frequently than patients with AKI who were
in the risk or injury stages (20.4% vs. 5.9%, respectively;
pZ 0.009; Table 6). Bacteremia (adjusted OR, 5.86; 95% CI,
1.10e31.1; multivariable p Z 0.038) was identified as an
independent predictor for incomplete recovery of renal
function at discharge, after adjusting for the covariates of
lactate (p Z 0.026), shock with vasopressor use
(p < 0.001), failure-stage AKI (p Z 0.009), bacteremia
(p Z 0.031), and for the suspected confounder of an age
older than 65 years (Table 7).
Discussion
Diabetic ketoacidosis can result in severe fluid depletion,
accompanied by marked metabolic disturbance; it is sur-
prisingly rare for it to be complicated by acute renal fail-
ure.3 To our knowledge, only a few case reports have
demonstrated complicated DKA with rhabdomyolysis or
thrombotic thrombocytopenic purpura contributing to
acute renal failure.2,17,18 The present study was conducted
retrospectively to increase our comprehension of the rela-
tionship between DKA (specifically DKA that is precipitated
by an infectious disease) and AKI. The pathophysiology of
DKA illustrates that stress, infection, or insufficient insulin
Table 4 Multivariate analysis of factors associated with the development of failure-stage acute kidney injury in infection-
precipitated diabetic ketoacidosis
Non-AKI, risk,
injury, (n Z 106 )
AKI in failure
stage, (n Z 54)
Univariate
p value
Adjusted odds
ratio
95% CI Multivariate
p value
Corrected Na (mmol/L) 140.6  6.5 147.2  11.0 < 0.001 1.062 1.003e1.124 0.039*
Initial plasma glucose (mg/dL) 495.1  165.8 712.9  259.9 < 0.001 1.003 1.000e1.005 0.041*
DKA severity 0.003
Mild grade 13 (12.3) 1 (1.9) 1 (reference)
Moderate grade 35 (33.0) 9 (16.7) 4.91 0.37e65.78 0.23
Severe grade 54 (54.7) 44 (81.5) 13.41 1.07e168.83 0.045*
APACHE II score 16.7  5.3 21.3  7.2 < 0.001 1.08 1.006e1.160 0.033*
*Multivariate p < 0.05.
The data are presented as n (%) or as the mean þ the standard deviation.
AKI Z acute kidney injury; APACHE Z Acute Physiology and Chronic Health Evaluation; CI Z confidence interval; DKA Z diabetic
ketoacidosis; HCO3 Z bicarbonate; Na Z sodium.
668 Y.-C. Cheng et al.therapy reduces effective insulin and increases the con-
centrations of counter-regulatory hormones (e.g., cate-
cholamines, cortisol, glucagon, and growth hormone),
which further contributes to hyperglycemia and ketoaci-
dosis.1 Hyperglycemia will facilitate osmotic diuresis, loss
of water and electrolytes, dehydration, and impaired renal
function. Furthermore, increasing evidence indicates that
hyperglycemic crises are associated with a severe inflam-
matory state that is characterized by an elevated level of
proinflammatory cytokines (e.g., tumor necrosis factor-a,Table 5 Severity of illness and clinical outcomes for infection-
Infection-precipitated DKA Total episodes
(n Z 160)
No
(n
Severity of illness
DKA severity
Mild grade 14 (8.8) 2 (
Moderate grade 44 (27.5) 9 (
Severe grade 102 (63.7) 10
APACHE II score 18.2  6.4 18.
Shock with vasopressor use 17 (10.6) 5 (
Complicated or severe infection state 46 (28.7) 4 (
Bacteremia 29 (18.1) 4 (
Inappropriate initial antimicrobial therapy 37 (23.1) 3 (
Clinical outcomes
Length of hospital stay (d) 13.5  12.6 12.
Recovery of renal function at discharge
Complete recovery 123 (88.5)a d
Partial recovery 6 (4.3)b d
Non-recovery 10 (8.1)c d
Hospital mortality 9 (5.6) 3 (
a 123 of 139 episodes of AKI had complete recovery of renal functio
b 6 of 139 episodes of AKI had partial recovery of renal function.
c 10 of 139 episodes of AKI had non-recovery of renal function.
*p < 0.05 among the four subgroups: non-AKI, AKI in risk stage, injur
The data are presented as n (%) or as the mean  the standard devia
AKI Z acute kidney injury; APACHE Z Acute Physiology and Chronicinterleukin-b, -6, and -8) even in the absence of obvious
infection.19 All of these parameters return to near-normal
values with insulin therapy and hydration within 24 hours.
In addition, patients with DKA presented with an elevated
body temperature, tachycardia, tachypnea, or leukocytosis
for which a predisposing infection state was documented.
This indicated that these patients met the criteria of sepsis.
In the pathogenesis of septic AKI, inflammation and
acute tubular apoptosis have been implicated in septic
patients with hyperdynamic circulation.20,21 In this study,precipitated diabetic ketoacidosis
n-AKI
Z 21)
AKI (n Z 139) p
Risk
(n Z 27)
Injury
(n Z 58)
Failure
(n Z 54)
9.5) 5 (18.5) 6 (10.3) 1 (1.9) 0.02*
42.9) 7 (25.9) 19 (32.8) 9 (16.7)
(47.6) 15 (55.6) 33 (56.9) 44 (81.5)
3  4.9 13.8  5.7 17.4  4.8 21.3  7.2 < 0.001*
26.3) 0 3 (5.7) 9 (18) 0.014*
19.0) 9 (33.3) 16 (27.6) 17 (31.5) 0.688
19.0) 4 (14.8) 12 (20.7) 9 (16.7) 0.909
15.0) 6 (24.0) 14 (24.6) 14 (26.9) 0.767
2  9.4 13.2  11.1 11.1  6.9 16.6  17.7 0.134
0.073
26 (96.3) 54 (93.1) 43 (79.6)
1 (3.7) 2 (3.4) 3 (5.6)
0 2 (3.4) 8 (14.8)
14.3) 0 1 (1.7) 5 (9.3) 0.055
n.
y stage, failure stage.
tion.
Health Evaluation; DKA Z diabetic ketoacidosis.
Table 6 Clinical outcomes of failure-stage acute kidney injury in infection-precipitated diabetic ketoacidosis
Clinical outcomes Non-AKI, risk, injury, (n Z 106) AKI in failure stage, (n Z 54) p
Length of hospital stay (d) 11.9  8.6 16.6  17.7 0.068
Incomplete recovery of renal function at discharge 5 (5.9)a 11 (20.4) 0.009*
Hospital mortality 4 (3.8) 5 (9.3) 0.167
a 5 of 85 episodes with AKI in risk and injury stages had incomplete recovery of renal function at discharge.
*p < 0.05. The data are presented as n (%) or as the mean þ the standard deviation.
AKI Z acute kidney injury.
Infection-precipitated DKA and AKI 669however, patients with infection-precipitated DKA who
developed AKI seemed to have a lower mean age
(44.7 16.1 years), a higher incidence of AKI (86.9%) on the
basis of the RIFLE criteria, but lower hospital mortality
(4.3%), compared to previous studies of AKI in critically ill
patients such as patients with severe sepsis and septic
shock. In two separate studies, patients in the intensive
care unit (ICU) who developed AKI had a mean age of 62.5
years7 and 68.5 years,8 an AKI incidence of 67%7 and 10.8%8,
and ICU mortality rate of 17.1%7 and 36.3%8. For severe
sepsis-associated AKI or septic shock-associated AKI, based
on the RIFLE criteria, recent retrospective studies report
that patients in the septic AKI group had a mean age of
64.9e68 years, an AKI incidence of 57.7e64.4%, and a
hospital mortality rate of 16.4e59.5%.20,22,23 The observa-
tion that younger patients developed AKI in our study may
be because most (56%) patients in this specific population
of DKA were 18e44 years and 24% of patients were 45e65
years.1 In adult patients with DKA, a mortality rate of up to
22% for patients older than 65 years and 2% for younger
patients has been reported.24 Death in these conditions is
rarely the result of the metabolic complications of hyper-
glycemia or ketoacidosis, but is associated with the un-
derlying precipitating illness.
A systemic review and meta-analyses of 31 observational
studies, which enrolled more than 500,000 patients,
demonstrated a significantly increased risk of AKI in criti-
cally ill patients with an older age, diabetes, probable hy-
pertension, high baseline creatinine, heart failure, sepsis/
systemic inflammatory response syndrome, use of nephro-
toxic drugs, high severity of disease scores, use of vaso-
pressors/inotropes, or high risk or emergency surgery.25
For patients with infection-precipitated DKA in this
current study, a high corrected Na level (adjusted OR,Table 7 Independent risk factor for incomplete recovery of rena
diabetic ketoacidosis who developed acute kidney injury
Renal outcome Complete recovery
(n Z 123)
Incomplete rec
(n Z 16)
Elderly ＞65 y 11 (8.9) 4 (25)
Lactate (mmol/L) 2.4  1.8 6.6  6.3
Shock with vasopressor use 6 (5.4) 6 (46.2)
AKI in failure stage 43 (35.0) 11 (68.8)
Bacteremia 19 (15.4) 6 (37.5)
*Univariate p < 0.05.
**Multivariate p < 0.05.
The data are presented as n (%) or as the mean  standard deviation
AKI Z acute kidney injury; CI Z confidence interval.1.062; p Z 0.039), a high initial plasma glucose level
(adjusted OR, 1.003; p Z 0.041), severe grade of DKA
(adjusted OR, 13.41; p Z 0.045), and high APACHE II score
(adjusted OR, 1.08; p Z 0.033) were independent risk
factors for the development of failure-stage AKI, but it was
not associated with a complicated or severe infection state,
shock with vasopressor use, bacteremia, or inappropriate
initial antimicrobial therapy. The mechanisms of DKA-
associated AKI are most likely associated with the osmotic
effect of hyperglycemia, hypovolemia, and metabolic
complications of ketoacidosis.3,26 The findings of our study
indicate that the development of failure-stage AKI in
infection-precipitated DKA may be similar to these
mechanisms.
Acute kidney injury is an independent risk factor for
mortality and significantly prolongs the hospital stay of
critically ill patients, which multiple studies have
confirmed.5,7,15 Furthermore, there was almost a linear
increase in the odds ratio for hospital mortality from AKI in
the risk to failure stage.6e8,15 However, our study demon-
strated that failure-stage AKI in infection-precipitated DKA
was not associated with a longer length of hospital stay and
higher hospital mortality, whereas it was associated with a
higher frequency of incomplete recovery of renal function
at discharge. Adjusting for covariates, bacteremia was
identified as an independent predictor of incomplete re-
covery of renal function at discharge. Piccinni et al15 report
that septic patients have more severe AKI and are more
likely to receive renal replacement therapy with less fre-
quency of renal function recovery in all incident admissions
in 10 ICUs in Italy. Furthermore, a high serum lactate level
tended to be associated with poor renal outcome.
Increased serum lactate concentrations imply inadequate
tissue oxygenation and organ dysfunction, which respond tol function at discharge in patients with infection-precipitated
overy Univariate
p value
Adjusted odds
ratio
95% CI Multivariate
p value
0.073 0.477 0.04e6.34 0.575
0.026* 1.26 0.99e1.60 0.056
< 0.001* 3.35 0.39e28.67 0.269
0.009* 3.06 0.60e15.71 0.18
0.031* 5.86 1.10e31.1 0.038**
.
670 Y.-C. Cheng et al.glycolysis promoted by stress.27 In a recent health tech-
nology assessment on the use of lactate levels in critically
ill patients, the serum lactate concentration had a place in
risk-stratification in the emergency department and in the
ICU.28 In addition, recent literature has demonstrated good
results for using the serum lactate level as a prognostic
measure and for therapeutic decisions and clinical classi-
fication in sepsis.29
There are limitations to our study. First, the retrospec-
tive nature of this study hindered the completeness of data
acquisition (e.g., no data were available on urine output,
which is a determinant in the RIFLE classification). Second,
the data were collected from a single hospital; therefore,
the incidence, severity, and outcomes of diseases may be
biased for a relatively small specific cohort. Third, the
duration of follow-up of renal outcome was short and there
was a diverse end point at discharge.
In conclusion, the present study provided the de-
mographic characteristics of infection-precipitated DKA
and risk factors for the development of failure-stage AKI
(based on the RIFLE classification), and its relevant clinical
outcomes, which seem to differ in patients with severe
sepsis-associated AKI or septic shock-associated AKI. For
patients with infection-precipitated DKA, the treating
clinician should be alert and aggressively monitor renal
function if a patient presents with risk factors associated
with the development of failure-stage AKI. When it occurs,
bacteremia predicts a poor renal prognosis.
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